sleep apnoeaDrShivagoDec 15, 20240 min readwww.reuters.comEU drugs regulator backs Mounjaro's sleep apnea use without fresh approval for LillyThe European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it has benefit in treating a sleep disorder without approving it specifically for the disease, the company said.
update on GLPhttps://www.reuters.com/business/healthcare-pharmaceuticals/who-set-back-use-weight-loss-drugs-adults-globally-raises-cost-issue-2025-05-01/
Weight loss TabletsEli Lilly: A New Leader Is Coming Could the long-running obesity drugs leadership anchored by the Denmark-headquartered Novo Nordisk (...
Comments